Financials in USD. Standardized financial statements.
A compact view of how Nanobac Pharmaceuticals, Incorporated turns revenue into operating income and net income.
| Metric | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 1999 | FY 1998 | FY 1997 | FY 1996 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $17,621 | $225,086 | $656,802 | $358,361 | $482,815 | $11,555 | $6.84M | $8.77M | $9.94M | $8.88M |
| Revenue Growth? | -92.2% | -65.7% | +83.3% | -25.8% | +4078.4% | -99.8% | -22.0% | -11.7% | +12.0% | 0.0% |
| Cost of Revenue? | $14,519 | $79,805 | $229,446 | $100,470 | $333,122 | $4,316 | $4.41M | $5.39M | $5.33M | $4.85M |
| Gross Profit? | $3,102 | $145,281 | $427,356 | $257,891 | $149,693 | $7,239 | $2.43M | $3.39M | $4.61M | $4.03M |
| Gross Margin? | +17.6% | +64.5% | +65.1% | +72.0% | +31.0% | +62.6% | +35.5% | +38.6% | +46.4% | +45.4% |
| Operating Expenses? | $4.92M | $4.96M | $3.27M | $7.86M | $2.85M | $1.48M | $4.80M | $5.44M | $5.85M | $4.79M |
| Operating Income? | $4.91M | $4.81M | $2.84M | $7.60M | $2.70M | $1.48M | $2.37M | $2.05M | $1.24M | $759,768 |
| EBITDA? | -$5.93M | -$4.23M | -$2.86M | -$6.88M | -$2.52M | -$1.48M | -$1.33M | -$720,120 | $204,713 | $450,477 |
| Income Before Tax | -$6.58M | -$4.97M | -$3.69M | -$7.82M | -$2.76M | -$1.48M | -$2.74M | -$2.68M | -$1.91M | -$1.24M |
| Income Tax Expense | $1.66M | $158,819 | $849,646 | $274,395 | $999,280 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$6.58M | -$4.97M | -$3.69M | -$7.87M | -$3.70M | -$1.48M | -$2.74M | -$2.68M | -$1.91M | -$1.24M |
| EPS? | $0.00 | $-0.02 | $-0.02 | $-0.05 | $-0.05 | $-0.07 | $-1.23 | $-1.21 | $-2.42 | $-1.93 |
| Diluted EPS? | $0.00 | $-0.02 | $-0.02 | $-0.05 | $-0.05 | $-0.04 | $-1.23 | $-1.21 | $-2.42 | $-1.93 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality